The lyophilization process consists of three phases: freezing, sublimation, and desorption. The freezing phase impacts the crystal structure that influences the drying rate and contributes to batch uniformity.
In sterile lyophilization, liquid-loaded vials can nucleate over a range of time with different degrees of supercooling, resulting in inter-batch varied ice crystal sizes which impact product resistance to drying.
VERISEQ® Nucleation is a controlled nucleation technology capable of producing sterile cryogenic ice fog and circulating it within a lyophilizer chamber to ensure reliable and prompt nucleation of vial contained pharmaceutical formulations.
As a result, vial to vial variance is reduced, ice crystals are larger, and control of the lyophilization process is enhanced.
In a recent application in India, the lab-scale VERISEQ® controlled nucleation system was installed for a pharmaceutical product which has critical residual moisture and batch uniformity requirements. The controlled nucleation system was retrofit to a lyophilizer at the India facility. During onsite startup, full nucleation was achieved with 2ml, 5ml, 10 ml, 20ml, and 100ml vials.
The exclusive tech videos shot during Achema 2024 are now available on our dedicated website